GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pennant Group Inc (NAS:PNTG) » Definitions » Peter Lynch Fair Value

PNTG (Pennant Group) Peter Lynch Fair Value : $13.18 (As of Dec. 12, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Pennant Group Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Pennant Group's PEG is 1. Pennant Group's 5-Year TTM EBITDA Growth Rate is 19.85. Pennant Group's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $0.66. Therefore, the Peter Lynch Fair Value for today is $13.18.

As of today (2024-12-12), Pennant Group's share price is $30.01. Pennant Group's Peter Lynch fair value is $13.18. Therefore, Pennant Group's Price to Peter Lynch Fair Value Ratio for today is 2.28.


The historical rank and industry rank for Pennant Group's Peter Lynch Fair Value or its related term are showing as below:

PNTG' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 2.28   Med: 3.67   Max: 4.51
Current: 2.28


During the past 8 years, the highest Price to Peter Lynch Fair Value Ratio of Pennant Group was 4.51. The lowest was 2.28. And the median was 3.67.


PNTG's Price-to-Peter-Lynch-Fair-Value is ranked worse than
69.52% of 187 companies
in the Healthcare Providers & Services industry
Industry Median: 1.38 vs PNTG: 2.28

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Pennant Group Peter Lynch Fair Value Historical Data

The historical data trend for Pennant Group's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pennant Group Peter Lynch Fair Value Chart

Pennant Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - -

Pennant Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.47 - 4.39 8.07 13.18

Competitive Comparison of Pennant Group's Peter Lynch Fair Value

For the Medical Care Facilities subindustry, Pennant Group's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pennant Group's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Pennant Group's Price-to-Peter-Lynch-Fair-Value falls into.



Pennant Group Peter Lynch Fair Value Calculation

Pennant Group's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 19.85 *0.664
=13.18

Pennant Group's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.66.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Pennant Group  (NAS:PNTG) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 19.85 instead of 15 in this case.

Pennant Group's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=30.01/13.18
=2.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pennant Group Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Pennant Group's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Pennant Group Business Description

Traded in Other Exchanges
Address
1675 East Riverside Drive, Suite 150, Eagle, ID, USA, 83616
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
Executives
Joanne Stringfield director C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, SUITE 120, EAGLE ID 83616
Brent Guerisoli officer: President 1675 E RIVERSIDE DR, SUITE 150, EAGLE ID 83616
Jennifer Freeman officer: Chief Financial Officer C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, SUITE 120, EAGLE ID 83616
Lynette Walbom officer: Chief Financial Officer 1675 E. RIVERSIDE DR., SUITE 150, EAGLE ID 83616
John J Gochnour officer: Chief Operating Officer C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, SUITE 100, EAGLE ID 83616
Barry M Smith director 4800 N SCOTTSDALE RD, SUITE 5000, SCOTTSDALE AZ 85251
John G. Nackel director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Christopher R. Christensen director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Morris Gregory K Sr. director 1675 E RIVERSIDE DR, SUITE 150, EAGLE ID 83616
Daniel H Walker director, officer: See Remarks C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, STE 150, EAGLE ID 83616
Derek J Bunker officer: See Remarks C/O THE PENNANT GROUP, INC., 1675 E. RIVERSIDE DRIVE, STE 150, EAGLE ID 83616
Scott E Lamb director ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Roderic W Lewis director
Covey Stephen M R director
Ensign Group, Inc 10 percent owner 29222 RANCHO VIEJO RD., SUITE 127, SAN JUAN CAPISTRANO CA 92675